Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates

作者: Jason Park , Thomas Mattessich , Steven M. Jay , Atu Agawu , W. Mark Saltzman

DOI: 10.1016/J.JCONREL.2011.06.025

关键词: Drug deliveryCombinatorial chemistryBiotinylationConjugateDrug carrierAvidinPLGAStereochemistryBiodistributionLinoleic acidChemistry

摘要: Biodegradable polymeric nanoparticles are widely recognized as efficacious drug delivery vehicles, yet the rational engineering of nanoparticle surfaces in order to improve biodistribution, reduce clearance, and/or targeting remains a significant challenge. We have previously demonstrated that an amphiphilic conjugate avidin and palmitic acid can be used modify poly(lactic-co-glycolic acid) (PLGA) particle display functional groups, allowing for facile attachment biotinylated ligands or steric stabilization. Here, we hypothesized incorporation, density, stability surface-presented could modulated through varying lipophilicity its fatty partner. tested this hypothesis by generating set novel conjugates incorporating common acids. found conjugation linoleic resulted ~60% increase incorporation on surface compared avidin-palmitic acid, which exhibited highest previous studies. Further, acid-avidin yielded with enhanced ability bind method; modified avidin-linoleic bound ~170% more biotin-HRP than those made ~1300% particles without conjugated avidin. Most critically, increased ligand density anti-CD4-targeted formulated 5% binding CD4(+) T cells. Thus conclude facilitates PLGA nanoparticles, resulting enhancement cellular targeting.

参考文章(37)
Jerzy W. Kupiec-Weglinski, Mohamed H. Sayegh, Hans Dieter Volk, Manfred Lehmann, Enver Akalin, Kazuhiko Onodera, Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. Journal of Immunology. ,vol. 157, pp. 1944- 1950 ,(1996)
A. Beletsi, Z. Panagi, K. Avgoustakis, Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA–PEG diblock copolymers International Journal of Pharmaceutics. ,vol. 298, pp. 233- 241 ,(2005) , 10.1016/J.IJPHARM.2005.03.024
Thejani E. Rajapaksa, Mary Stover-Hamer, Xiomara Fernandez, Holly A. Eckelhoefer, David D. Lo, Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery Journal of Controlled Release. ,vol. 142, pp. 196- 205 ,(2010) , 10.1016/J.JCONREL.2009.10.033
S. Maher, A. Bothwell, D. Margulies, M Corr, A. Slanetz, L. Boyd, M. Jelonek, S Khilko, B. al-Ramadi, Y. Kim, T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity Science. ,vol. 265, pp. 946- 949 ,(1994) , 10.1126/SCIENCE.8052850
Sarbari Acharya, Fahima Dilnawaz, Sanjeeb K. Sahoo, Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials. ,vol. 30, pp. 5737- 5750 ,(2009) , 10.1016/J.BIOMATERIALS.2009.07.008
P. Couvreur, F. Puisieux, Nano- and microparticles for the delivery of polypeptides and proteins Advanced Drug Delivery Reviews. ,vol. 10, pp. 141- 162 ,(1993) , 10.1016/0169-409X(93)90046-7
Kenneth A. Davis, Barnaby Abrams, Sujata B. Iyer, Robert A. Hoffman, James E. Bishop, Determination of CD4 antigen density on cells: Role of antibody valency, avidity, clones, and conjugation Cytometry. ,vol. 33, pp. 197- 205 ,(1998) , 10.1002/(SICI)1097-0320(19981001)33:2<197::AID-CYTO14>3.0.CO;2-P
Gerd Horneff, Gerd R. Burmester, Frank Emmrich, Joachim R. Kalden, Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibody Arthritis & Rheumatism. ,vol. 34, pp. 129- 140 ,(1991) , 10.1002/ART.1780340202
F. Velge-Roussel, P. Breton, X. Guillon, F. Lescure, N. Bru, D. Bout, J. Hoebeke, Immunochemical characterization of antibody-coated nanoparticles Cellular and Molecular Life Sciences. ,vol. 52, pp. 803- 806 ,(1996) , 10.1007/BF01923993